Korea United Pharm. Inc. exports superior medicines to over 40 countries worldwide. Established with the core philosophy of 'Leaping forward as a global company', Korea United Pharm. Inc. made an early entry into the pharmaceutical export market. We currently export incrementally modified drugs (IMDs) - which are advanced formulations of existing medicines - oncology products, vitamins, and more to over 40 different countries. We hold subsidiaries in Vietnam, Philippines, Myanmar, Indonesia, and Thailand, and operate a local production factory in Vietnam as well.

The key factor that has enabled us to achieve these accomplishments is 'research'. We invest over 13% of our annual revenue in research and development, ensuring that 100% of our products are produced through our own research and development efforts. This commitment to R&D has resulted in a diverse pipeline in various fields, including oncology, cardiovascular, and respiratory systems. Unlike other pharmaceutical companies, we have a strength in IMD products and are leading its market.

The ultimate goal of Korea United Pharm.Inc. is to seize the world market, which accounts for 99% of the entire pharmaceutical market, and to be recognized as "a multinational pharmaceutical company with a Korean owner".